Communiqués Geron Corporation

Actions

GERN

US3741631036

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2026			Varia. 5j.	Varia. 1 janv.
1,420 ^USD	+2,90%		-8,97%	+7,58%

13/07	Geron Corporation annonce la nomination de Chinmaya Rath au poste de Chief Business Officer	CI
08/06	Transcript : Geron Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:40 AM

Communiqués

15/07	Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 14, 2026	AQ
14/07	Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	AQ
13/07	Geron Announces Appointment of Chinmaya Rath as Chief Business Officer	AQ
19/06	Geron Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
18/06	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
01/06	Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference	AQ
18/05	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
12/05	First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026	AQ
06/05	Geron : Corporate Presentation	PU
06/05	Geron : Corporate Presentation May 2026	PU
06/05	Geron: Q1 Earnings Snapshot	AQ
06/05	Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights	AQ
05/05	Geron Plans to Present at Upcoming Investor Conferences	AQ
22/04	Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026	AQ
20/04	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
14/04	Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	AQ
13/04	Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary	AQ
06/04	Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference	AQ
26/03	Geron Announces Appointment of New Members to its Board of Directors	AQ
18/03	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
25/02	Geron : Corporate Presentation	PU
25/02	Geron : Corporate Deck - February 2026 FINAL	PU
25/02	Geron: Q4 Earnings Snapshot	AQ
25/02	Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights	AQ
23/02	Geron Plans to Present at Upcoming Investor Conferences	AQ